384 Single-cell transcriptomics, proteomics and in vitro cytotoxicity of allogeneic cryopreserved natural killer cell therapy GTA002 identify potent effector signatures
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1827577847604051968 |
|---|---|
| author | Jan Spanholtz Monica Raimo Daniëlle Steenmans Amanda van Vliet Anna-Maria Georgoudaki Adil Duru Denise Vodegel |
| author_facet | Jan Spanholtz Monica Raimo Daniëlle Steenmans Amanda van Vliet Anna-Maria Georgoudaki Adil Duru Denise Vodegel |
| author_sort | Jan Spanholtz |
| collection | DOAJ |
| first_indexed | 2024-03-08T21:32:41Z |
| format | Article |
| id | doaj.art-e6580f6e89ab4074ad1f2471a9ecc5c5 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-08T21:32:41Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-e6580f6e89ab4074ad1f2471a9ecc5c52023-12-21T04:50:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0384384 Single-cell transcriptomics, proteomics and in vitro cytotoxicity of allogeneic cryopreserved natural killer cell therapy GTA002 identify potent effector signaturesJan Spanholtz0Monica Raimo1Daniëlle Steenmans2Amanda van Vliet3Anna-Maria Georgoudaki4Adil Duru5Denise Vodegel6Glycostem Therapeutics, Oss, NetherlandsGlycostem Therapeutics, Oss, NetherlandsGlycostem Therapeutics, Oss, NetherlandsGlycostem Therapeutics, Oss, NetherlandsGlycostem Therapeutics, Oss, NetherlandsGlycostem Therapeutics, Oss, NetherlandsGlycostem Therapeutics, Oss, Netherlands |
| spellingShingle | Jan Spanholtz Monica Raimo Daniëlle Steenmans Amanda van Vliet Anna-Maria Georgoudaki Adil Duru Denise Vodegel 384 Single-cell transcriptomics, proteomics and in vitro cytotoxicity of allogeneic cryopreserved natural killer cell therapy GTA002 identify potent effector signatures Journal for ImmunoTherapy of Cancer |
| title | 384 Single-cell transcriptomics, proteomics and in vitro cytotoxicity of allogeneic cryopreserved natural killer cell therapy GTA002 identify potent effector signatures |
| title_full | 384 Single-cell transcriptomics, proteomics and in vitro cytotoxicity of allogeneic cryopreserved natural killer cell therapy GTA002 identify potent effector signatures |
| title_fullStr | 384 Single-cell transcriptomics, proteomics and in vitro cytotoxicity of allogeneic cryopreserved natural killer cell therapy GTA002 identify potent effector signatures |
| title_full_unstemmed | 384 Single-cell transcriptomics, proteomics and in vitro cytotoxicity of allogeneic cryopreserved natural killer cell therapy GTA002 identify potent effector signatures |
| title_short | 384 Single-cell transcriptomics, proteomics and in vitro cytotoxicity of allogeneic cryopreserved natural killer cell therapy GTA002 identify potent effector signatures |
| title_sort | 384 single cell transcriptomics proteomics and in vitro cytotoxicity of allogeneic cryopreserved natural killer cell therapy gta002 identify potent effector signatures |
| work_keys_str_mv | AT janspanholtz 384singlecelltranscriptomicsproteomicsandinvitrocytotoxicityofallogeneiccryopreservednaturalkillercelltherapygta002identifypotenteffectorsignatures AT monicaraimo 384singlecelltranscriptomicsproteomicsandinvitrocytotoxicityofallogeneiccryopreservednaturalkillercelltherapygta002identifypotenteffectorsignatures AT daniellesteenmans 384singlecelltranscriptomicsproteomicsandinvitrocytotoxicityofallogeneiccryopreservednaturalkillercelltherapygta002identifypotenteffectorsignatures AT amandavanvliet 384singlecelltranscriptomicsproteomicsandinvitrocytotoxicityofallogeneiccryopreservednaturalkillercelltherapygta002identifypotenteffectorsignatures AT annamariageorgoudaki 384singlecelltranscriptomicsproteomicsandinvitrocytotoxicityofallogeneiccryopreservednaturalkillercelltherapygta002identifypotenteffectorsignatures AT adilduru 384singlecelltranscriptomicsproteomicsandinvitrocytotoxicityofallogeneiccryopreservednaturalkillercelltherapygta002identifypotenteffectorsignatures AT denisevodegel 384singlecelltranscriptomicsproteomicsandinvitrocytotoxicityofallogeneiccryopreservednaturalkillercelltherapygta002identifypotenteffectorsignatures |